Why is weight harder to lose with PCOS?
Your body runs on chronically elevated insulin. When insulin stays high, your body prioritises fat storage: especially around your abdomen. Your muscles become insulin-resistant and stop efficiently taking up glucose. Everything gets stored as fat instead of burned for energy, which basically means your metabolism is working against weight loss.
Problem one is metabolic. Problem two is neurological. PCOS disrupts your hunger and fullness signals. Women with PCOS have altered ghrelin patterns and a blunted GLP-1 response (the hormone that signals fullness). This means you feel hungry sooner and stay hungry longer than women without PCOS eating identical calories. It's not weakness. It's a measurable difference in your neurochemistry.
A 2021 review by Barber et al. in the Journal of Clinical Medicine found that women with PCOS frequently have a lower resting metabolic rate relative to body composition than controls. Meaning the same caloric intake may produce greater weight gain. The authors note that this metabolic difference is directly related to hyperinsulinaemia and androgen excess, not willpower or adherence.
Does diet type matter more than calories?
Most advice gets this wrong: it focuses on calories, not insulin. For PCOS, lowering your dietary glycaemic load (how much blood sugar the carbs you eat will spike) works better than generic calorie restriction. Studies show low-glycaemic diets outperform regular "healthy" diets even when total calories are identical. The difference: better fasting insulin, steadier periods, lower androgens. It's not about eating less. It's about eating smarter carbs.
Higher protein helps too. It keeps you full longer and preserves muscle mass: which directly improves insulin sensitivity independent of weight loss. Most doctors don't mention that: you can improve your insulin resistance without losing weight, just by changing your muscle composition and what you eat.
Exercise type matters in PCOS. Resistance training builds the muscle mass that improves insulin sensitivity independent of weight loss. A 2020 meta-analysis found both aerobic and resistance training improved HOMA-IR (insulin resistance measure) in women with PCOS, but resistance training showed additional benefits for testosterone levels. A combination of both is supported by current guidelines.
What about medications that support weight management?
Metformin improves insulin sensitivity and can modestly help with weight. Inositol supplements show some benefit for insulin and weight too. GLP-1 drugs (like semaglutide) are gaining attention for PCOS. They address the blunted GLP-1 response women with PCOS have, but they require doctor supervision and are prescription only.
What to ask your doctor
- Ask for a fasting insulin and HOMA-IR calculation, not just fasting glucose: normal glucose can coexist with significant insulin resistance in PCOS.
- Ask which PCOS phenotype you have: the four phenotypes have different metabolic risk profiles and may respond differently to dietary and lifestyle interventions.
- Ask for a referral to an accredited dietitian with PCOS experience: a structured, personalised approach is more effective than general advice.
- If you have tried lifestyle changes consistently without improvement, ask about insulin-sensitising medications or a referral to an endocrinologist.
Weight in PCOS is a medical issue, not a willpower issue
If you have PCOS and have struggled with weight despite genuine effort, this is a recognised feature of the condition. Not a personal failing. Bringing this to your doctor with the context of your PCOS diagnosis opens the door to metabolic investigations and management approaches that go beyond generic diet advice. Ask for an endocrinology referral if standard doctor support has not been adequate.
References
- Teede HJ, Tay CT, Laven J, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. PubMed
- Barber TM, Hanson P, Weickert MO, Franks S. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042. PubMed
- Patten RK, Boyle RA, Moholdt T, et al. Exercise Interventions in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Front Physiol. 2020;11:606. PubMed